Current Preventions and Treatments of aGVHD: From Pharmacological Prophylaxis to Innovative Therapies

Graft versus host disease (GVHD) is one of the main causes of mortality and the reason for up to 50% of morbidity after hematopoietic stem cell transplantations (HSCT) which is the treatment of choice for many blood malignancies. Thanks to years of research and exploration, we have acquired a profou...

Descripción completa

Detalles Bibliográficos
Autores principales: Naserian, Sina, Leclerc, Mathieu, Shamdani, Sara, Uzan, Georges
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773902/
https://www.ncbi.nlm.nih.gov/pubmed/33391276
http://dx.doi.org/10.3389/fimmu.2020.607030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773902/
https://www.ncbi.nlm.nih.gov/pubmed/33391276
http://dx.doi.org/10.3389/fimmu.2020.607030

Ejemplares similares